Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Meal-centric Insulin Dosing for Optimized Post-Prandial Glucose Control in People Using Multiple Daily Injections

NCT04667182 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT04667182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04667182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Meal-centric Insulin Dosing for Optimized Post-Prandial Glucose Control in People Using Multiple Daily Injections
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Withdrawn
Start date
January 25, 2021
Completion date
December 6, 2021
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes